Ciox’s service helps healthcare provider clients achieve data liquidity and improve health outcomes by streamlining access to patient records from other providers’ systems and facilitating the coding and analysis of that data. The new funding will aid in the development of the Digital Patient Clone platform, which standardizes de-identified clinical data from disparate sources for research and development.
Merck’s innovation fund invests in emerging digital health technology companies. Its most recent contribution will enable Ciox to partner with other companies in the fund’s oncology-focused portfolio, according to managing director David Rubin, PhD, and therefore advance clinical research and the discovery of new treatments.
More articles on data analytics:
Analytics startup Health Catalyst raises IPO to $172M
Healthcare software company Phreesia goes public: 3 things to know
Atrium Health deploys automation, data analytics for medication management
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.